The paper presents comparative research on the clinical picture and distinctive features of the therapy in dysthymia patients who used opiate drugs and drug addiction. 26 patients with dysthymia complicated by addiction to opiate drugs and 22 heroin addicts were examined. The received results will allow doctors to pay attention to the necessary details for the detection of relevant affective disorders, reduce the period of detecting affective disorders that significantly influence the choice of a rational therapy in the status of patients and also to build specific projections regarding patients.
Introduction
Although abundant research has been done on the clinic and treatment of comorbid state in drug in narcology and psychiatry, the bulk of this work is dedicated to the combination of drug addiction and schizophrenia; while there is a less work related to the comorbidity of drug addiction and dysthymic disorders (Alexandrova, 2005; Bryun, Geht, and Polunina, 2001; George and Krystal, 2000) . The importance of diagnosing dysthymic disorders and the differentiation of their variances in drug addicted patients are evident. It helps to pick a rational therapy for arresting the symptoms; otherwise, attempts to conduct a therapy without eliminating patients' affective pathology of any intensity tend to yield no results (Ivanets and Chirko, 2002; Linskiy, Minko, and Samoylova, 2003; Litvintsev, Kochetkova, Arbuzov et al., 2003) . A highly qualified drug abuse expert and psychiatrist will not have much difficulty diagnosing schizophrenia-related states. In these cases it comes in the form of distinct affective pictures that help determine psychotic symptoms, besides addictive symptoms (attributed to drug addiction), and prescribe rational treatment. Things are a lot trickier when we face cases of dysthymia that used to be attributed to masked depression (Guzikov, Zobnev, and Revzin, 1999; Bukstein, Brent, and Kaminer, 1989) . The impact and pinpointing of nosologic belonging of comorbid dysthymic disorders at an early post-withdrawal period makes it possible to optimize psychopharmatherapy in progress, thereby creating conditions for an improvement of the quality and duration of remission in this group of patients (Revzin, 1999; Sofronov, 2002) .
Materials and methods
The goal set was to do comparative research into the clinical picture and distinctive features of the therapy of dysthymia patients who used opiate drugs and drug addiction. For this purpose, 26 patients affected by dysthymia aggravated by addiction to opiate drugs (DAAOD) and 22 heroin addicts have been examined. All the patients gave their consent to examination and treatment. Patients suffering from dysthymia stated long periods of dysthymic states which they experienced before they used pathologically active substances (PAS) and sought help primarily from general practitioners, complaining of low mood, asthenia and anhedonia. The parents of part of the dysthymia patients reported their children showed deviant behavior in adolescence (leaving homes, excessive inclination to conflicts) -all this was combined with subdepressive states, which also led to treatments by doctors of various specialties. The clinic-dynamic characteristics of the patients are provided in Table 1 . As the table shows, dysthymia patients develop addiction to psychoactive substances a bit later than drug addicts. As a rule, patients start introducing themselves to PAS (including alcohol) later than age 20. Next, they go through polydrug abuse and go on to use hard drugs; in our case, opiates (heroin, codeine substances). The vast majority of DAAOD patients develop withdrawals over a longer period of time than drug addicts. Those affected with dysthymia often show pathological signs long before drug addiction develops (autochthonous, often seasonal, states of changed affectivity, irrationally long bouts of depression, low mood, as a reaction to traumatizing situations). At the same time, subdepressive and sometimes "hidden" symptoms occur just as do lower activity and lower work efficiency as well as an anxiety component of depression, thoughts of low esteem and failure.
Other occurrences include somatic accompaniment of psychopathological disorders (worsening appetite, weight loss, insomnia, feeling debilitated after waking up, etc). What is meant here is the time of occurrence of affective disorders in relation to the development of drug addiction, unlike "secondary" affectivity which occurs due to chronic narcotic intoxication and which doesn't normally have signs of endogenous nature. In these cases patients do not show marked drug-associated changes in their personality while signs of narcotic degradation in them occur much later than in heroin addicts. Affective disorders detected in dysthymia patients occur in acute withdrawal symptoms, in post-withdrawal symptoms (up to 1 month after the withdrawals are stopped), and further, in the phase of remission (up to half a year after withdrawal symptoms are stopped). These patients usually start using drugs in an effort to remove psychological ill-being (to raise their mood and activity in simple and apathetic subdepressive state, to get rid of anxiety in anxiety depression). This is the difference of the group of patients in question from patients affected with heroin addiction, who, at initial stages of drug use, show dominating traditional and hedonistic motives. The most common reason for starting drug use in dysthymia patients is ataractic motive . The most common occurrence in ataractic disorders is an aspiration to remove affective tension, to become more active, to get rid of the state of inactivity, and to boost energy. Often withdrawn, shy and, as they believe, uninteresting, the patients try to become uninhibited, which they believe they can achieve by using PAS. In some cases, use of PAS removes inner nervousness, anxiety, anguish, tension and inner discomfort. In other cases, it gives a feeling of lightness, ease in communication with people, helps to overcome the habitual shyness or closure. DAAOD patients' use of narcotic substances is combined, varied and often accompanied with alcohol, which is not characteristic of conventional drug addicts. In spite of the fact that the majority of patients undergo unsuccessful treatment for drug addiction, narcologists do not raise the question of diagnosing dysthymia, which is not surprising because long periods of PAS use hides dysthymia. A lengthy systematic use of drugs is characteristic of the majority of patients with dysthymic disorders prior to the occurrence of all component of withdrawal, while fullblown dependence reveals an incomplete structure of withdrawals, a slight expression of somatoneurologic component and a predominance of the psychological component in withdrawal with a recurrent longing for drugs. A broad spectrum of affective disorders in withdrawal draws particular attention. Affective disorders in withdrawal may be represented by anxiety, anxious-depressive, anxious-dysphoric, anxious-phobic, anxiousdepressive-hypochondriac, asthenic-depressive-hypochondriac, and dysphoric syndromes. In comparison with heroin addicted patients, more complex affective symptoms in withdrawal have been observed; heroin addicted patients have manifested more simple syndromes (anxiety, depressive, dysphoric, asthenic, psychoorganic).
Results and discussion
An important point in the diagnostics of dysthymia is the presence in their anamnesis of long-lasting spontaneous and therapeutic remissions, which link affective symptoms with drug abuse. An analysis of the motives in the recurrence of drug use in these patients usually testifies to a previous change in the affective state. The majority of dysthymia patients in an early post-withdrawal period, much like heroin addicts, do not have designs on an absolute refusal of drugs, which they consider a remedy. Along with pharmacotherapy, this circumstance requires relevant psychotherapeutic measures. Patients with dysthymia who use opium substance show a milder and slower development of withdrawal symptoms as well as short periods of withdrawal as compared with drug addicts. Once they desist from using drugs, the algic, vegetative component of withdrawal symptoms in dysthymia patients is more marked than in opium drug addicts, while mental components in the form of longing for a drug and scenes of taking PAS in their dreams may take place. More often, of all the diversity of dysthymia forms in our observations, the use of drugs falls under the psychopathic-like and neurosis-like (asthenic and psychosthenia-like options) of dysthymia types. In patients with neurosis-like dysthymia the use of opium drugs does not lead to the development of withdrawal symptoms, remaining on the level of PAS abuse. In our view, there is a necessity to qualify the fact of the use of psychoactive substance by dysthymia patients; in our case, opium drugs. In the International Classification of Diseases (ICD-10) there is a gradation of the PAS use, with diagnostic criteria for determining drug addiction or a fact of PAS abuse. Based on the data we have received, it becomes evident that the patients under examination who have the neurosis-like form of dysthymia do not earn the necessary number of points and do not fall in the diagnostic category of drug addiction. Thus, these patients' use of PAS was not dose dependent; their tolerance and, subsequently, their dose of drug did not change. As a rule, they used PAS when it was available and rarely made an effort to seek sources of a drug. Also, sometimes the patients stopped using PAS on their own, oftentimes spontaneously with no significant withdrawal symptoms. Those with the neurosis-like dysthymia most likely fall in the diagnostic category of psychoactive substance abuse. Quite a different picture emerges when it comes to patients with psychopathic-like dysthymia. These patients use PAS significantly longer than those with neurosis-like dysthymia. They have more marked pathological longing for drugs, they attempt to get new doses of PAS, steal valuables and money from friends and relatives in order to buy a drug. They may be spotted in public places, at work or school in narcotic condition. When their relatives place them in drug rehab facilities, they are forced to stop using PAS, but once they leave the facility they may revert to the use of drugs right away. In other words, we have observed in them criteria for assessing the presence of drug addiction and may classify such patients as opium drug addicts. In the occurrence of disorders in dysthymia moods prior to the occurrence of withdrawals, we have observed a lengthy period of systematic drug use with a quick growth of tolerance during depressive state and loss of quantity control, but with a slow formation of withdrawal symptoms, its incomplete structure and, in some cases, the absence of withdrawal signs. When DAAOD patient retain their permanent longing for drugs in combination with rather marked affective disorders in this period, this is attributed to the low quality of remission and their short duration as compared with heroin drug addicts. Thus, in DAAOD patients psychopathological manifestations play a considerable role in the remission of drug addiction. They require identification and relevant treatment; otherwise, a quick recurrence of drug use will occur. In treating PAS patients, amidst antidepressants we introduced neuroleptics to the therapy, which made it possible to overcome patients' resistance to medication. A more active suppression of PAS symptoms occurs in DAOOD patients than in drug addicts. The degree of clarity of a symptom was evaluated on a 0 to 3 point basis; (0 -no symptom, 1 -slight, 2 -moderately expressed, 3 -clearly expressed). Dysthymia-1 -psychopathic-like; dysthymia-2 -neurosis-like. Table 3 reveals the therapeutic action of the combined system amid basic therapy in patients of the 2 groups. A coherent clinical effect is seen both in DAAOD patients and drug addicted patients. In the majority of patients, the decrease in anxiety was accompanied by excessive sedation, sleepiness in daytime, increased physical debilitation and weakness. These states were toughly endured by drug addicted patients and often prevented the further increase in dosage of medication unlike patients with dysthymia complicated by PAS use. In assessing the results of treatment in the subgroups of patients Thus, DAAOD patients start taking PAS at an older age as compared with drug addicts. In the vast majority of DAAOD patients, the formation of withdrawal symptoms occurs for longer periods than in drug addicts. When subjected to therapy, in DAAOD patients the PAS symptoms are suppressed more actively than in drug addicts. At all stages of observations the number of unwanted side effects was validly higher in the drug addict group as compared with DAAOD patients.
Conclusion
The reference points in the differential diagnostics of affective disorders in drug addiction at an early post-withdrawal period include: the absence of drug-associated personality change in the DAAOD group, which is characteristic of heroin addicts; the prevalence of affective disorders in the structure of withdrawal syndrome, and also testify to the need to carry out thorough anamnesis research and diagnostics of mood disorders, comorbid drug addiction. The detection of dysthymic pathology with carrying out a differentiated psychopharmacotherapy in the post-withdrawal period and supporting the therapy of affective disorders in remission helps to significantly improve the quality and duration of remission in this group of patients. These results will allow doctors to pay attention to the necessary details for the detection of relevant affective disorders, reduce the period of detecting affective disorders that markedly influence the choice of a rational therapy in the status of patients, to avoid the habitually unsuccessful attempts to carry out traditional anti-narcotics therapy in patients, and also to build specific projections regarding patients of the group studied.
